Development of HPV16 mouse and dog models for more accurate prediction of human vaccine efficacy.
Totain E, Lindner L, Martin N, Misseri Y, Iché A, Birling MC, Sorg T, Herault Y, Bousquet-Melou A, Bouillé P, Duthoit C, Pavlovic G, Boullier S.
Totain E, et al.
Lab Anim Res. 2023 Jun 12;39(1):14. doi: 10.1186/s42826-023-00166-3.
Lab Anim Res. 2023.
PMID: 37308929
Free PMC article.
In this study, we used a candidate therapeutic vaccine named C216, similar to the ProCervix candidate therapeutic vaccine, to validate new mouse and dog HPV preclinical models. ProCervix has shown promising results with classical subcutaneous murine TC-1 cell tumor isograf …
In this study, we used a candidate therapeutic vaccine named C216, similar to the ProCervix candidate therapeutic vaccine, to validate new …